New psoriasis pill enters final testing phase
Disease control
Not yet recruiting
This study tests a drug called ponesimod in 300 adults with moderate-to-severe plaque psoriasis. The goal is to see if it is safe and helps control the skin condition. Participants will take the drug and be monitored for side effects and skin improvement. This is not a cure, but …
Phase: PHASE3 • Sponsor: Vanda Pharmaceuticals • Aim: Disease control
Last updated May 01, 2026 15:58 UTC